Cargando…

How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?

OBJECTIVE: Adequate methods of combining T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) to assess complete response (CR) to chemoradiotherapy (CRT) for rectal cancer are obscure. We aimed to determine an algorithm for combining T2WI and DWI to optimally suggest CR on MRI using visua...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Jong Keon, Lee, Chul-min, Park, Seong Ho, Kim, Jong Hoon, Kim, Jihun, Lim, Seok-Byung, Yu, Chang Sik, Kim, Jin Cheon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390818/
https://www.ncbi.nlm.nih.gov/pubmed/34132075
http://dx.doi.org/10.3348/kjr.2020.1403
_version_ 1783743149118586880
author Jang, Jong Keon
Lee, Chul-min
Park, Seong Ho
Kim, Jong Hoon
Kim, Jihun
Lim, Seok-Byung
Yu, Chang Sik
Kim, Jin Cheon
author_facet Jang, Jong Keon
Lee, Chul-min
Park, Seong Ho
Kim, Jong Hoon
Kim, Jihun
Lim, Seok-Byung
Yu, Chang Sik
Kim, Jin Cheon
author_sort Jang, Jong Keon
collection PubMed
description OBJECTIVE: Adequate methods of combining T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) to assess complete response (CR) to chemoradiotherapy (CRT) for rectal cancer are obscure. We aimed to determine an algorithm for combining T2WI and DWI to optimally suggest CR on MRI using visual assessment. MATERIALS AND METHODS: We included 376 patients (male:female, 256:120; mean age ± standard deviation, 59.7 ± 11.1 years) who had undergone long-course CRT for rectal cancer and both pre- and post-CRT high-resolution rectal MRI during 2017–2018. Two experienced radiologists independently evaluated whether a tumor signal was absent, representing CR, on both post-CRT T2WI and DWI, and whether the pre-treatment DWI showed homogeneous hyperintensity throughout the lesion. Algorithms for combining T2WI and DWI were as follows: ‘AND,’ if both showed CR; ‘OR,’ if any one showed CR; and ‘conditional OR,’ if T2WI showed CR or DWI showed CR after the pre-treatment DWI showed homogeneous hyperintensity. Their efficacies for diagnosing pathologic CR (pCR) were determined in comparison with T2WI alone. RESULTS: Sixty-nine patients (18.4%) had pCR. AND had a lower sensitivity without statistical significance (vs. 62.3% [43/69]; 59.4% [41/69], p = 0.500) and a significantly higher specificity (vs. 87.0% [267/307]; 90.2% [277/307], p = 0.002) than those of T2WI. Both OR and conditional OR combinations resulted in a large increase in sensitivity (vs. 62.3% [43/69]; 81.2% [56/69], p < 0.001; and 73.9% [51/69], p = 0.008, respectively) and a large decrease in specificity (vs. 87.0% [267/307]; 57.0% [175/307], p < 0.001; and 69.1% [212/307], p < 0.001, respectively) as compared with T2WI, ultimately creating additional false interpretations of CR more frequently than additional identification of patients with pCR. CONCLUSION: AND combination of T2WI and DWI is an appropriate strategy for suggesting CR using visual assessment of MRI after CRT for rectal cancer.
format Online
Article
Text
id pubmed-8390818
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society of Radiology
record_format MEDLINE/PubMed
spelling pubmed-83908182021-09-04 How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer? Jang, Jong Keon Lee, Chul-min Park, Seong Ho Kim, Jong Hoon Kim, Jihun Lim, Seok-Byung Yu, Chang Sik Kim, Jin Cheon Korean J Radiol Gastrointestinal Imaging OBJECTIVE: Adequate methods of combining T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) to assess complete response (CR) to chemoradiotherapy (CRT) for rectal cancer are obscure. We aimed to determine an algorithm for combining T2WI and DWI to optimally suggest CR on MRI using visual assessment. MATERIALS AND METHODS: We included 376 patients (male:female, 256:120; mean age ± standard deviation, 59.7 ± 11.1 years) who had undergone long-course CRT for rectal cancer and both pre- and post-CRT high-resolution rectal MRI during 2017–2018. Two experienced radiologists independently evaluated whether a tumor signal was absent, representing CR, on both post-CRT T2WI and DWI, and whether the pre-treatment DWI showed homogeneous hyperintensity throughout the lesion. Algorithms for combining T2WI and DWI were as follows: ‘AND,’ if both showed CR; ‘OR,’ if any one showed CR; and ‘conditional OR,’ if T2WI showed CR or DWI showed CR after the pre-treatment DWI showed homogeneous hyperintensity. Their efficacies for diagnosing pathologic CR (pCR) were determined in comparison with T2WI alone. RESULTS: Sixty-nine patients (18.4%) had pCR. AND had a lower sensitivity without statistical significance (vs. 62.3% [43/69]; 59.4% [41/69], p = 0.500) and a significantly higher specificity (vs. 87.0% [267/307]; 90.2% [277/307], p = 0.002) than those of T2WI. Both OR and conditional OR combinations resulted in a large increase in sensitivity (vs. 62.3% [43/69]; 81.2% [56/69], p < 0.001; and 73.9% [51/69], p = 0.008, respectively) and a large decrease in specificity (vs. 87.0% [267/307]; 57.0% [175/307], p < 0.001; and 69.1% [212/307], p < 0.001, respectively) as compared with T2WI, ultimately creating additional false interpretations of CR more frequently than additional identification of patients with pCR. CONCLUSION: AND combination of T2WI and DWI is an appropriate strategy for suggesting CR using visual assessment of MRI after CRT for rectal cancer. The Korean Society of Radiology 2021-09 2021-05-26 /pmc/articles/PMC8390818/ /pubmed/34132075 http://dx.doi.org/10.3348/kjr.2020.1403 Text en Copyright © 2021 The Korean Society of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Gastrointestinal Imaging
Jang, Jong Keon
Lee, Chul-min
Park, Seong Ho
Kim, Jong Hoon
Kim, Jihun
Lim, Seok-Byung
Yu, Chang Sik
Kim, Jin Cheon
How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
title How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
title_full How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
title_fullStr How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
title_full_unstemmed How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
title_short How to Combine Diffusion-Weighted and T2-Weighted Imaging for MRI Assessment of Pathologic Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer?
title_sort how to combine diffusion-weighted and t2-weighted imaging for mri assessment of pathologic complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer?
topic Gastrointestinal Imaging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390818/
https://www.ncbi.nlm.nih.gov/pubmed/34132075
http://dx.doi.org/10.3348/kjr.2020.1403
work_keys_str_mv AT jangjongkeon howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer
AT leechulmin howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer
AT parkseongho howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer
AT kimjonghoon howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer
AT kimjihun howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer
AT limseokbyung howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer
AT yuchangsik howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer
AT kimjincheon howtocombinediffusionweightedandt2weightedimagingformriassessmentofpathologiccompleteresponsetoneoadjuvantchemoradiotherapyinpatientswithrectalcancer